Geriatric Medical
US$ 23.34
glp 1 treatment GLP-1 Medications Show Promise as First Drug Therapy for Sleep Apnea GLP-1 Weight Loss - CasaGlow
Description
Owens DR, Monnier L, Hanefeld M
While patient preference is clearly shifting toward non-injectable options, injectables are projected to retain a 75% market share by 2035, not the minority
Slightly lower rates were seen with the lower dose 0.75 mg dulaglutide arm
One study reported that GLP-1 is negatively correlated with body mass index (BMI) and that it appears to increase dentate gyrus neurogenesis based on immunostaining images (Weina et al., 2018)
Potentially life-threatening
doi: 10.3390/biom11020286 49 FeethamCHCollabollettaVWorthAAShoopRGroomSHardingCet al
